{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:54:23Z","timestamp":1791640463681,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.neurol.2008.11.020","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:25:19Z","timestamp":1232616319000},"page":"137-143","source":"Crossref","is-referenced-by-count":13,"title":["Anticorps dans la myasth\u00e9nie"],"prefix":"10.1016","volume":"165","author":[{"given":"B.","family":"Eymard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2008.11.020_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.186.4158.55","article-title":"Serum globulin in myasthenia gravis: inhibition of \u03b1-bungarotoxin binding to acetylcholine receptors","volume":"186","author":"Almon","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.11.020_bib2","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.74.5.2130","article-title":"Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulin","volume":"74v","author":"Appel","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.11.020_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2008.03.006","article-title":"Severe neonatal myasthenia due to maternal anti-MuSK antibodies","volume":"18","author":"B\u00e9hin","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2008.11.020_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in Myasthenia Gravis. Immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib5","first-page":"1S25","article-title":"Modulation de la myasth\u00e9nie exp\u00e9rimentale par les IgIV","volume":"151","author":"Berrih-Aknin","year":"2000","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.neurol.2008.11.020_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long term correlation of binding and bungarotoxin-blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0960-8966(94)E0029-8","article-title":"Recurrent congenital arthrogryposis leading to diagnosis of myasthenia gravis in an initially asymptomatic mother","volume":"5","author":"Barnes","year":"1995","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.neurol.2008.11.020_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","article-title":"IgG from \u201cseronegative\u201d myasthenia gravis patients binds to muscle cell line TE671, but not to human acetyl receptor","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib9","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/mus.880171208","article-title":"Passive transfer of seronegative myasthenia gravis to mice","volume":"17","author":"Burges","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2008.11.020_bib10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1212\/WNL.31.11.1440","article-title":"Antibody-induced degradation of acetylcholine in myasthenia gravis: clinical correlates and pathogenic significance","volume":"31","author":"Conti-Tronconi","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2008.11.020_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies crosslink acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N Eng J Med"},{"key":"10.1016\/j.neurol.2008.11.020_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.11.020_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/301611a0","article-title":"Naturally occuring antiidiotypic antibodies in myasthenia gravis patients","volume":"301","author":"Dwyer","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2008.11.020_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJM198302173080718","article-title":"Autoantibodies to acetylcholine in myasthenia gravis","volume":"308","author":"Elias","year":"1983","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurol.2008.11.020_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1987.tb51301.x","article-title":"The membrane attack complex of complement at the endplate in myasthenia gravis","volume":"505","author":"Engel","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib17","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalised seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2008.11.020_bib18","first-page":"6","article-title":"R\u00f4le du thymus dans la physiopathologie de la myasth\u00e9nie","volume":"151","author":"Eymard","year":"1995","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0022-510X(88)90006-8","article-title":"Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical state","volume":"86","author":"Eymard","year":"1988","journal-title":"J. Neurol Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib20","first-page":"696","article-title":"Myasth\u00e9nie et grossesse\u00a0: \u00e9tude clinique et immunologique de of 42 cas","volume":"145","author":"Eymard","year":"1989","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.11.020_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0896-8411(91)90017-7","article-title":"Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance","volume":"4","author":"Eymard","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.neurol.2008.11.020_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1569-2590(08)60188-3","article-title":"Neonatal myasthenia gravis clinical and pathophysiological aspects","volume":"2","author":"Eymard","year":"1997","journal-title":"Adv Organ Bio"},{"key":"10.1016\/j.neurol.2008.11.020_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"82","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.11.020_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2008.11.020_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/WNL.43.5.983","article-title":"The \u201cembryonnic\u201d gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle","volume":"43","author":"Horton","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI5943","article-title":"Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenital causes deformity in mice","volume":"103","author":"Jacobson","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2008.11.020_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extraocular domain of rat muscle specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.neurol.2008.11.020_bib28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulins accelerate acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.11.020_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.41.4.520","article-title":"Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies predictive and gain in diagnostic certainty","volume":"41","author":"Lanska","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib30","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK positive and anti- MuSK negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0022-510X(83)90095-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part I. Relation to clinical parameters in 250 patients","volume":"58","author":"Limburg","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptors in myasthenia gravis: prevalence, clinical correlates and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.28.2.130","article-title":"Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome","volume":"28","author":"Lindstrom","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410410404","article-title":"Acetylcholine receptor expression in human, extraocular muscles and their susceptibility to myasthenia gravis","volume":"41","author":"MacLennan","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.nmd.2008.06.368","article-title":"Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor","volume":"18","author":"Maggi","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2008.11.020_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM197603252941303","article-title":"Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis","volume":"294","author":"Mittag","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.11.020_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/WNL.38.1.138","article-title":"Neonatal myasthenia gravis: a new clinical and immunological appraisal on 30 cases","volume":"38","author":"Morel","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2008.11.020_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.410320419","article-title":"Ryanodine receptor autoantiobodies in myasthenia gravis patients with a thymoma","volume":"32","author":"Mygland","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib41","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Nicks","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000307751.20968.f1","article-title":"A transient neonatal myasthenic syndrome with anti-Musk antibodies","volume":"70","author":"Nicks","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.1993.tb22889.x","article-title":"Differences in acetylcholine receptor antibody interactions between extraocular and extremity muscle fibers","volume":"681","author":"Oda","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in Musk antibody positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2008.11.020_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-8981(90)90110-E","article-title":"Anti-skeletal muscles antibodies in the sera from myasthenic patients with thymoma: Identification of anti-myosin, actomyosin, actin, and \u03b1-actinin antibody by solid phase radioimmunoassay and western blotting analysis","volume":"187","author":"Ohta","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.neurol.2008.11.020_bib46","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/01.WNL.0000129274.12702.92","article-title":"MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG","volume":"62","author":"Ohta","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0022-510X(85)90144-3","article-title":"Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3: the effect of thymectomy","volume":"69","author":"Oosterhuis","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.11.020_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.880090505","article-title":"Antimuscle and anti-acetylcholine receptor antibodies in myasthenia gravis","volume":"9","author":"Penn","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2008.11.020_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.880080311","article-title":"Measurement of junctional acetylcholine receptor antibodies in myasthenia gravis: clinical correlates","volume":"8","author":"Pestronk","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2008.11.020_bib51","first-page":"202","article-title":"Extraocular muscle susceptibility to myasthenia gravis. Unique immunological environment?","volume":"132","author":"Soltys","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib52","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib53","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2008.11.020_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott Med J"},{"key":"10.1016\/j.neurol.2008.11.020_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.11.020_bib56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis measured by monoclonal antibodies","volume":"70","author":"Tzartos","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2008.11.020_bib57","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.136.9.3231","article-title":"Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rates","volume":"136","author":"Tzartos","year":"1986","journal-title":"J. Immunol"},{"key":"10.1016\/j.neurol.2008.11.020_bib58","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1073\/pnas.85.9.2899","article-title":"Localization of the main immune region of human acetylcholine receptor to residues 67-76 of the alpha subunit","volume":"85","author":"Tzartos","year":"1988","journal-title":"Proc Natl Sci USA"},{"key":"10.1016\/j.neurol.2008.11.020_bib59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.1990.tb03296.x","article-title":"Neonatal Myasthenia Gravis: Antigenic specificities of antibodies in sera from mothers and their infants","volume":"80","author":"Tzartos","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.neurol.2008.11.020_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-5728(86)90098-6","article-title":"Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis","volume":"12","author":"Vernet Der Garabedian","year":"1986","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2008.11.020_bib61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI117369","article-title":"Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor","volume":"94","author":"Vernet Der Garabedian","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2008.11.020_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In vitro synthesis of acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"i","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2008.11.020_bib63","first-page":"257","article-title":"Acetylcholine receptor antibody characteristics in Myasthenia Gravis. Patients with generalized myasthenia or disease restricted to ocular muscles","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin Exp Immuno"},{"key":"10.1016\/j.neurol.2008.11.020_bib64","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.33.10.1276","article-title":"Acetylcholine receptor antibodies and clinical response to thymectomy in myasthenia gravis","volume":"33","author":"Vincent","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1987.tb51286.x","article-title":"Antibody heterogeneity and specificity in Myasthenia Gravis","volume":"505","author":"Vincent","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2008.11.020_bib67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmune mechanisms in thymoma and thymus","volume":"1132","author":"Wilcox","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of Muscle-specific tyrosine kinase-antibody positive myasthenia gravis","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurol.2008.11.020_bib70","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.37.8.1329","article-title":"Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis","volume":"37","author":"Yamamoto","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.11.020_bib71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis. Tight association with thymoma and heterogoneity of non tyymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.11.020_bib72","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/01.WNL.0000128042.28877.C3","article-title":"Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese","volume":"62","author":"Yeh","year":"2004","journal-title":"Neurology"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708006875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708006875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:00:14Z","timestamp":1684864814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378708006875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0035378708006875"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2008.11.020","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}